Physician profile
Eileen Alexander
NPI 1447488150
$1,069.55
in general payments reported to CMS, 2019-2025
15 companies · $224 in 2025
The $224 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.62 · 2020: $17.12 · 2021: $134 · 2022: $127 · 2023: $299 · 2024: $196 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $456.38 | 2021-2025 | Bexsero, Pediarix, Rotarix |
| Sanofi Pasteur INC. | $109.93 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $101.84 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Collegium Pharmaceutical, INC. | $96.49 | 2025 | Jornay Pm |
| Sobi, INC | $38.63 | 2019 | |
| Pfizer INC. | $36.73 | 2021 | |
| Alk-Abello, INC | $35.58 | 2023 | Ragwitek, Grastek, Odactra |
| Ironshore Pharmaceuticals INC. | $33.20 | 2020-2023 | Jornay Pm |
| Acadia Pharmaceuticals INC | $31.56 | 2025 | Daybue |
| Nestle Healthcare Nutrition INC. | $29.51 | 2021-2022 | |
| Adlon Therapeutics L.P. | $21.64 | 2019 | |
| Seqirus USA INC | $21.45 | 2024 | Flucelvax |
| Hologic Sales and Service, LLC | $21.29 | 2025 | Aptima |
| Welch Allyn | $19.60 | 2021 | |
| Cranial Technologies, INC | $15.72 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.